In vivo, lenti-BMP1 primary tumours were smaller than those of the controls (~100 mg vs. ~210 mg (p < 0.01)) and shCOL1A1 (~500 mg) or lenti-BMP1 + shCOL1A1 (600 mg) tumours. This evidence concerns the gene BMP1 and neoplasm.